Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
BLX 0.22ELF.TO -0.08RY.TO 2.45PEY.TO -0.14CP.TO -2.3BRK.B -4.89MSFT -8.38META -19.79
Daily Stock Opinions and Ratings
The ultimate 360° Tracker Your financial life in one place, automatically
Stockchase Opinions

Jim Cramer - Mad MoneyCatalentCTLTBUYFeb 08, 2023

They make the tools that helped Moderna make the Covid vaccine. Roared during the pandemic, then crashed in 2022, but is soaring now. Rumoured that Danaher could take this over.

Jim Cramer - Mad MoneyJim Cramer - Mad Money
Unknown
Unlock Rating
N/A

Stock price when the opinion was issued

$63.48

As of Dec 17, 2024. Market Open.

biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
Get Signals Create your Watchlist

You might be interested:

DON'T BUY

Catalent(CTLT)

Nov 29, 2023

They had a financial problem. Stay away for a while.

Photo of Jim Cramer - Mad MoneyJim Cramer - Mad MoneyUnlock Rating
$39.77

Stock price when the opinion was issued

$63.48

As of Dec 17, 2024. Market Open.

biotechnologypharmaceutical
DON'T BUY

Catalent(CTLT)

Mar 22, 2023

Danaher (he owns) or Illumina could buy CTLT, at least that's the talk. Until something happens, he won't buy this.

Photo of Jim Cramer - Mad MoneyJim Cramer - Mad MoneyUnlock Rating
N/A

Stock price when the opinion was issued

$63.48

As of Dec 17, 2024. Market Open.

biotechnologypharmaceutical

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

AVGO 21.56$398.27
CCO.TO 1.82$152.86
TOU.TO -0.62$60.17
BTE.TO -0.06$5.85
ADM -1.74$76.28

Today's Top Picks

BLX 0.22$59.46
ELF.TO -0.08$16.9
RY.TO 2.45$283.96
PEY.TO -0.14$24.77
CP.TO -2.3$122.5

Popular Articles

Latest Sell Signals

OTEX.TO -0.11$30.85
BSX -0.91$46.01
GIL.TO 4.26$74.65
SHOP.TO 0.41$158.9
WCN.TO 1.06$220.65

Most Recent Experts

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Keith Richards

Keith Richards

ValueTrend Wealth Management

Joe Terranova

Joe Terranova

Virtus Investment Partners

Stephen Weiss, Founder, Short Hills Capital Partners

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Rob Sechan, Managing Partner, New Edge Capital

Rob Sechan, Managing Partner, New Edge Capital

New Edge Capital

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica